Lack of a point mutation of human DNA topoisomerase II in multidrug-resistant anaplastic thyroid carcinoma cell lines.
about
A phase II trial of fosbretabulin in advanced anaplastic thyroid carcinoma and correlation of baseline serum-soluble intracellular adhesion molecule-1 with outcomeAnaplastic thyroid cancer: a review of epidemiology, pathogenesis, and treatment.Anaplastic giant cell thyroid carcinoma.Anaplastic thyroid carcinoma: three protocols combining doxorubicin, hyperfractionated radiotherapy and surgery.
P2860
Q54605326-33AA8D38-7247-470D-A255-68A9DAC84D14Q54896604-3DB1946E-92C7-42D5-9F00-538339B06F43Q54900000-DB2243BE-96B9-48D7-A198-C0DC2ADCD86AQ54900614-394C11B1-0415-4AF6-9A74-FFC248BCA164Q54971817-315C782A-A8FA-4B8A-A124-A0D59654F158Q54971891-B0EE51D4-C7FE-4EC1-B7A2-8EDE998B4420Q54973227-6494B72C-9E06-40C2-9E37-170248DD1ADFQ54973228-640BFD09-622E-4AD2-80DA-63E7F5C1BC29Q54973229-CE553808-76AC-4F21-BA6F-25025370D709
P1343
Lack of a point mutation of human DNA topoisomerase II in multidrug-resistant anaplastic thyroid carcinoma cell lines.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Lack of a point mutation of hu ...... thyroid carcinoma cell lines.
@en
Lack of a point mutation of hu ...... thyroid carcinoma cell lines.
@nl
type
label
Lack of a point mutation of hu ...... thyroid carcinoma cell lines.
@en
Lack of a point mutation of hu ...... thyroid carcinoma cell lines.
@nl
prefLabel
Lack of a point mutation of hu ...... thyroid carcinoma cell lines.
@en
Lack of a point mutation of hu ...... thyroid carcinoma cell lines.
@nl
P2093
P4510
P1433
P1476
Lack of a point mutation of hu ...... c thyroid carcinoma cell lines
@en
P2093
P356
10.1016/S0304-3835(97)04742-3
P407
P577
1997-06-01T00:00:00Z